[Therapeutic effect and tolerance of sulfonamide trimethoprim combination (Bactrim)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004361:Drug Tolerance; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Therapeutische Wirksamkeit und Verträglichkeit eines Sulfonamid-Trimethoprim-Kombinationspräparates (Bactrim.